UNH Stock Price Today (August 2026) — UnitedHealth Group Incorporated Analysis & Key Metrics 2026-08-21
UnitedHealth Group Incorporated (UNH) is trading at $390.11, up 1.37% today (as of August 2026). The stock continues to show mixed signals with a short-term dip within a broader uptrend, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $475.23 (21.8% upside).
- Volatility remains elevated (17.23% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (40.00% YoY) alongside significant competitive pressures.
UNH Stock Analysis: Key Metrics & Valuation (August 2026)
Concise, actionable data for investors
UnitedHealth Group Incorporated - Historical Price & Volume
Market Cap
Enterprise Value: $412.54B
P/E Ratio
Forward P/E: 18.17
Revenue Growth
Year over Year
Analyst Target
+21.8% upside potential
Key Investor Questions About UNH
What investors need to know before buying
Based on current market data, UNH presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 35.25)
- Fundamentals say: Caution warranted (high leverage concerns)
UNH's growth trajectory depends on its ability to expand within the Healthcare Plans sector while managing margin pressures.
- Future growth will depend on performance in core Healthcare Plans operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for UNH investors include debt exposure and competitive dynamics in the Healthcare Plans industry.
- $73.33B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Healthcare Plans.
52-Week Trading Range
Over the past year, UNH stock traded between $239.50 and $461.62—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 17.23% annualized volatility and β=0.32, the stock exhibits low sensitivity to market moves—making UNH suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
What Does UnitedHealth Group (UNH) IRS Tax Scrutiny Mean For Investors?
UnitedHealth Group (NYSE:UNH) is facing IRS scrutiny over how it priced transactions with a foreign subsidiary, with the agency proposing sizable tax adjustments across multiple years. The IRS move focuses on transfer pricing and could significantly raise UnitedHealth Group's taxable income if the proposed changes are ultimately applied. UnitedHealth has said it plans to contest the proposed adjustments, keeping the timing and final financial impact uncertain for now. Regulators paying...
Is The Pullback In UNH Stock A Glitch Or A Warning?
The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.
Mark Cuban: “No Chance” Radiologists Get Replaced by AI. He Says the Real Target Is Elsewhere
Mark Cuban says AI will never replace radiologists, and his reasoning has nothing to do with capability. The real disruption, he argues, targets a different layer of medicine entirely, one worth hundreds of billions in enterprise value at some of the biggest names in healthcare.
Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?
UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.
The Hidden Tax Cost of JEPI’s Monthly Income Machine
JEPI's 8% monthly yield looks like an obvious win over SCHD's modest payout, but the IRS treats those two income streams in ways that can quietly flip the comparison depending on where you hold them.
Warren Buffett's Berkshire Hathaway Bought This Dividend Stock for a Reason. Here's Why Greg Abel Won't Sell.
Since taking over as CEO, Greg Abel has made some big portfolio moves, but there's one longtime Buffett holding even he won't touch.
AON Sees No Relief From Health-Cost Inflation: WTW, UNH & CNC in Focus
Aon expects U.S. employer health-care costs to rise 9.5% in 2027, intensifying pressure on benefits budgets and demand for cost-management services.
New Strong Buy Stocks for August 21st
MCY, ASMB, ONTO, BSET and UNH have been added to the Zacks Rank #1 (Strong Buy) List on August 21st, 2026.
Best Value Stocks to Buy for August 21st
MCY, SMCI and UNH made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 21st, 2026.
Best Income Stocks to Buy for August 21st
BSET, UNH and CCS made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 21st, 2026.
Explore More Analysis for UNH
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Frequently Asked Questions
Common investor questions about UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) is currently trading at $390.11. The RSI (14-day) is at 35.2, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $475.23 implies 21.8% upside from current levels. Volatility is low at 17.2% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for UnitedHealth Group Incorporated (UNH): The trailing P/E ratio is 29.92, which is in line with broader market averages. The forward P/E is 18.17, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.28, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 3.38. Price-to-Sales is 0.79. Valuation should be compared to Healthcare Plans industry peers for context, as different sectors trade at different multiples.
Based on 26 analysts covering UNH, the consensus price target is $475.23. This represents a 21.8% upside from the current price of $390.11. The range spans from a low target of $313.00 to a high target of $529.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, UnitedHealth Group Incorporated (UNH) pays a dividend with a current yield of approximately 2.38%. The annualized dividend rate is $4.42 per share. The payout ratio is 66.6%, which is moderate and suggests adequate earnings coverage for the dividend. The most recent ex-dividend date was 2026-06-15T00:00:00.000Z.
Key risks for UnitedHealth Group Incorporated (UNH) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Healthcare Plans sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is UnitedHealth Group Incorporated's (UNH) current debt and financial health profile: Total debt stands at $73.33B. The debt-to-equity ratio is 69.21, which is moderate and generally manageable for most companies. The current ratio is 0.78, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.47. The company holds $31.47B in cash and equivalents. Free cash flow is positive at $22.76B, providing a cushion for debt servicing and shareholder returns.